DrugPatentWatch Database Preview
Eagle Pharms Company Profile
What is the competitive landscape for EAGLE PHARMS, and when can generic versions of EAGLE PHARMS drugs launch?
EAGLE PHARMS has four approved drugs.
There are twenty-two US patents protecting EAGLE PHARMS drugs.
There are eighty-seven patent family members on EAGLE PHARMS drugs in thirty-one countries.
Summary for Eagle Pharms
| International Patents: | 87 |
| US Patents: | 22 |
| Tradenames: | 4 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Eagle Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eagle Pharms | BELRAPZO | bendamustine hydrochloride | SOLUTION;IV (INFUSION) | 205580-001 | May 15, 2018 | RX | Yes | Yes | 10,010,533 | Start Trial | Y | Start Trial | |||
| Eagle Pharms | BELRAPZO | bendamustine hydrochloride | SOLUTION;IV (INFUSION) | 205580-001 | May 15, 2018 | RX | Yes | Yes | 9,265,831 | Start Trial | Y | Start Trial | |||
| Eagle Pharms | RYANODEX | dantrolene sodium | FOR SUSPENSION;INTRAVENOUS | 205579-001 | Jul 22, 2014 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Eagle Pharms | ARGATROBAN IN SODIUM CHLORIDE | argatroban | INJECTABLE;INTRAVENOUS | 022434-001 | Jun 29, 2011 | RX | Yes | Yes | 7,589,106 | Start Trial | Y | Start Trial | |||
| Eagle Pharms | RYANODEX | dantrolene sodium | FOR SUSPENSION;INTRAVENOUS | 205579-001 | Jul 22, 2014 | RX | Yes | Yes | 8,110,225 | Start Trial | Y | Start Trial | |||
| Eagle Pharms | BENDEKA | bendamustine hydrochloride | SOLUTION;IV (INFUSION) | 208194-001 | Dec 7, 2015 | RX | Yes | Yes | 9,265,831 | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for EAGLE PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Injection | 100 mg/4 mL (25 mg/mL) multiple-dose vials | ➤ Subscribe | 2017-05-04 |
International Patents for Eagle Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2593582 | Start Trial |
| Norway | 20073722 | Start Trial |
| Croatia | P20161771 | Start Trial |
| Australia | 2004262507 | Start Trial |
| South Korea | 20180056804 | Start Trial |
| Japan | 2018197248 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
